Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide

Carola A.S. Arndt, A. G. Nascimento, G. Schroeder, P. J. Schomberg, J. P. Neglia, S. F. Sencer, T. L. Silberman, C. L. Moertel, J. K. Tillisch, J. S. Miser

Research output: Contribution to journalArticle

32 Scopus citations

Fingerprint Dive into the research topics of 'Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide'. Together they form a unique fingerprint.

Medicine & Life Sciences